DK1697033T3 - Method for cryogranulation and storage of allergens - Google Patents

Method for cryogranulation and storage of allergens

Info

Publication number
DK1697033T3
DK1697033T3 DK04803030.8T DK04803030T DK1697033T3 DK 1697033 T3 DK1697033 T3 DK 1697033T3 DK 04803030 T DK04803030 T DK 04803030T DK 1697033 T3 DK1697033 T3 DK 1697033T3
Authority
DK
Denmark
Prior art keywords
low temperature
temperature particles
relates
particles
storing
Prior art date
Application number
DK04803030.8T
Other languages
Danish (da)
Inventor
Martin Richter-Friis
Signe Kolmos Andersen
Original Assignee
Alk Abello As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alk Abello As filed Critical Alk Abello As
Priority claimed from PCT/DK2004/000878 external-priority patent/WO2005058474A1/en
Application granted granted Critical
Publication of DK1697033T3 publication Critical patent/DK1697033T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/02—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by dividing the liquid material into drops, e.g. by spraying, and solidifying the drops
    • B01J2/06—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by dividing the liquid material into drops, e.g. by spraying, and solidifying the drops in a liquid medium
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F26—DRYING
    • F26B—DRYING SOLID MATERIALS OR OBJECTS BY REMOVING LIQUID THEREFROM
    • F26B5/00—Drying solid materials or objects by processes not involving the application of heat
    • F26B5/04—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum
    • F26B5/06—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum the process involving freezing
    • F26B5/065—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum the process involving freezing the product to be freeze-dried being sprayed, dispersed or pulverised
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Mechanical Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Glanulating (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present invention relates to a volume production method for preparing active medicament components such as allergenic products. The present invention also relates to a container containing low temperature particles of liquid combinations of the allergenic products, and further relates to low temperature particles of the allergenic products. The method for preparing and storing low temperature particles for an active medicament is characterized by using a container containing low temperature medium (such as liquid nitrogen), and storing the low temperature particles in a same container. The low temperature particles do not undergo freeze-drying before storage and processing.
DK04803030.8T 2003-12-19 2004-12-17 Method for cryogranulation and storage of allergens DK1697033T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200301896 2003-12-19
US53167903P 2003-12-23 2003-12-23
PCT/DK2004/000878 WO2005058474A1 (en) 2003-12-19 2004-12-17 Cryogranulation and storage method for active pharmaceutical agents

Publications (1)

Publication Number Publication Date
DK1697033T3 true DK1697033T3 (en) 2011-06-27

Family

ID=34973435

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04803030.8T DK1697033T3 (en) 2003-12-19 2004-12-17 Method for cryogranulation and storage of allergens

Country Status (6)

Country Link
JP (1) JP4755992B2 (en)
CN (2) CN1894026B (en)
AT (1) ATE505263T1 (en)
DE (1) DE602004032262D1 (en)
DK (1) DK1697033T3 (en)
ES (1) ES2363342T3 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103127173B (en) * 2013-03-06 2015-01-21 苏州市红冠庄国药饮片有限公司 Atomizing multi-layer covering and crystallizing process for producing beer blood crystal
CN114160040B (en) * 2021-12-09 2022-07-12 广州风行乳业股份有限公司 Liquid nitrogen cryogenic granulation equipment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5242846B2 (en) * 1974-04-03 1977-10-27
CA2338766A1 (en) * 1998-07-31 2000-02-10 Eli Lilly And Company Cryogranulation of activated protein c
ATE462413T1 (en) * 2000-01-14 2010-04-15 Univ Brown Res Found METHOD FOR PRODUCING MICRONIZED FREEZE-DRIED PARTICLES
ATE414773T1 (en) * 2000-11-16 2008-12-15 Alk Abello As MUTANT ALLERGENS
AUPR750501A0 (en) * 2001-09-05 2001-09-27 Gauci, Mark Products comprising quantum of bioparticles and method for production thereof

Also Published As

Publication number Publication date
CN102657863A (en) 2012-09-12
ES2363342T3 (en) 2011-08-01
ATE505263T1 (en) 2011-04-15
JP2007514490A (en) 2007-06-07
JP4755992B2 (en) 2011-08-24
CN1894026A (en) 2007-01-10
CN1894026B (en) 2012-01-25
DE602004032262D1 (en) 2011-05-26

Similar Documents

Publication Publication Date Title
GEP20074234B (en) Cyclic protein tyrosine kinase inhibitors
MY145693A (en) A method of drying without freezing or bubbling
EA200700173A1 (en) POROUS TABLETS AS MEDIA FOR LIQUID COMPOSITIONS
EA200600164A1 (en) ZEOLITES FOR DOSING NITROGEN OXIDE
NO20050290L (en) Novel tetrahydropyridine derivatives as renin inhibitors
DE60042609D1 (en) MULTIPLE FORMS OF LIGANDS OF THE TNF SUPERFAMILY
ATE532781T1 (en) 5-(ACYLAMINO)INDAZOLE DERIVATIVES AS KINASE INHIBITORS
UA97234C2 (en) Sodium chloride solution for reconstituting lyophilized factor ix formulation
MX2007004841A (en) Triazoles useful as inhibitors of protein kinases.
ATE417917T1 (en) PRESERVATION OF SENSITIVE AMBIENT TEMPERATURE BIOLOGICAL SAMPLES THROUGH GLAZING
DK1697033T3 (en) Method for cryogranulation and storage of allergens
WO2004092727A3 (en) Compound libraries and methods for drug discovery
AU6924501A (en) Method for isolating and purifying a protein and resulting protein
DK1123079T3 (en) Bag to store and transport sterile powdered products and to produce solutions of the products in the bag
PL1689374T3 (en) Self-supporting films for pharmaceutical and food use
GEP20074183B (en) Indazole having analgesic activity
EVANS et al. Studies of nutrient media for tissue cells in vitro. IV. The effect of amino acid mixtures on the proliferation of the long-term strain 2071 of NCTC clone 929 of strain L cells
CY1108753T1 (en) PHARMACEUTICAL FORM SPRAY WHICH INCLUDES HYDRO ALCOHOL AND A CYCLUDE Dextrin
Wohlfarth Viscosity of the mixture (1) methyl methacrylate;(2) pentan-1-ol: Data extract from Landolt-Börnstein IV/25: Viscosity of Pure Organic Liquids and Binary Liquid Mixtures
Wohlfarth Dielectric constant of propane-1, 2-diol: Data extract from Landolt-Börnstein IV/17: Static Dielectric Constants of Pure Liquids and Binary Liquid Mixtures
Blagoeva et al. Numerical analysis of protein drugs release from lipid implants
Wohlfarth Viscosity of the mixture (1) butan-1-ol;(2) methyl methacrylate: Data extract from Landolt-Börnstein IV/25: Viscosity of Pure Organic Liquids and Binary Liquid Mixtures
NO20055836L (en) Intermediates useful in the synthesis of HIV protease inhibitors and methods for producing the same
Wohlfarth Dielectric constant of the mixture (1) propan-2-ol;(2) methyl methacrylate: Data extract from Landolt-Börnstein IV/17: Static Dielectric Constants of Pure Liquids and Binary Liquid Mixtures
Wohlfarth Dielectric constant of the mixture (1) 2-methylpropan-1-ol;(2) methyl methacrylate: Data extract from Landolt-Börnstein IV/17: Static Dielectric Constants of Pure Liquids and Binary Liquid Mixtures